Inhibrx Biosciences Inc
Inhibrx Biosciences Inc (INBX) Wheel Strategy
INBX wheel strategy scan found 37 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 565.8%.
Read more
Running a INBX wheel strategy lets you generate consistent premium income on Inhibrx Biosciences Inc while setting your own entry and exit prices on the underlying. Inhibrx Biosciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own INBX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best INBX wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on INBX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable INBX wheel from a losing one.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma.
The company was incorporated in 2024 and is based in La Jolla, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the INBX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your INBX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Sep 18, 2026 | 100.00 | $0.10 | $1.55 | -0.28 | 1 | 0% | 94.3% | 565.8% | 49 |
| Oct 16, 2026 | 100.00 | $3.00 | $7.50 | -0.37 | 29 | 0% | 56.6% | 94.4% | 4 |
| Oct 16, 2026 | 95.00 | $1.10 | $5.55 | -0.30 | 29 | 0% | 66.9% | 73.5% | 0 |
| Oct 16, 2026 | 90.00 | $0.25 | $5.13 | -0.25 | 29 | 0% | 76.5% | 71.7% | 8 |
| Nov 20, 2026 | 100.00 | $7.30 | $12.15 | -0.37 | 64 | 0% | 51.9% | 69.3% | 8 |
| Nov 20, 2026 | 95.00 | $5.00 | $9.50 | -0.32 | 64 | 0% | 59.0% | 57.0% | 6 |
| Nov 20, 2026 | 90.00 | $3.00 | $7.50 | -0.27 | 64 | 0% | 66.3% | 47.5% | 9 |
| Jan 15, 2027 | 95.00 | $9.00 | $13.95 | -0.32 | 120 | 0% | 53.7% | 44.7% | 1 |
| Nov 20, 2026 | 70.00 | $0.05 | $5.03 | -0.14 | 64 | 0% | 90.5% | 40.9% | 5 |
| Oct 16, 2026 | 85.00 | $1.80 | $2.75 | -0.17 | 29 | 0% | 84.7% | 40.7% | 66 |
As of September 22, 2026
Run the Wheel on INBX With Confidence
Find the best INBX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→